Clinical Trial Update: A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy [Phase 2]

View source ↗

Summary

This update outlines a Phase 2 clinical trial comparing a fixed-cycle regimen including orelabrutinib with BTK inhibitor monotherapy for chronic lymphocytic leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Orelabrutinib (orelabrutinib)

Snippet

Sponsor: Fei Li | Conditions: CLL/SLL | Phase 2 | Status: NOT_YET_RECRUITING